Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-09-05
DOI
10.1093/eurheartj/ehaa739
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
- (2020) Mauro Chiarito et al. LANCET
- Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
- (2020) Byeong-Keuk Kim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
- (2019) Dirk Sibbing et al. JACC-Cardiovascular Interventions
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
- (2019) Anna Franzone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
- (2018) Davide Capodanno et al. Nature Reviews Cardiology
- Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
- (2018) Jae Youn Moon et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
- (2018) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus
- (2017) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation – past, present and future perspectives
- (2017) Giuseppe Gargiulo et al. EuroIntervention
- A Critical Appraisal of Aspirin in Secondary Prevention
- (2016) Giuseppe Gargiulo et al. CIRCULATION
- Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
- (2016) S. Claiborne Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
- (2015) S. Schulz-Schupke et al. EUROPEAN HEART JOURNAL
- Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
- (2015) Robert A. Byrne et al. EUROPEAN HEART JOURNAL
- Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation
- (2015) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial
- (2014) Pascal Vranckx et al. EUROPEAN HEART JOURNAL
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A basic introduction to fixed-effect and random-effects models for meta-analysis
- (2010) Michael Borenstein et al. Research Synthesis Methods
- A re-evaluation of random-effects meta-analysis
- (2008) Julian P. T. Higgins et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started